🔗 Share this article Patients Stopping Anti-Obesity Jabs Put On Weight Far More Rapidly Than People Using Diet and Exercise Weight management involves long-term strategies. A recent study reveals that people who stop using popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight far faster than those who halt traditional lifestyle regimens. Research printed in a major health publication demonstrates that while obese people frequently drop about a fifth of their total mass while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit. "Individuals using these medications must be cognizant of the potential of quick weight regain when the treatment concludes," cautioned researcher Dr. Susan Jebb. Such speed of regain means a reversion to starting mass within about one and a half years. Weighing Treatments The research, which reviewed 37 of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills. Researchers note that people who shed pounds through diet and exercise usually experience a more gradual weight regain—around 0.1 kg a month—after stopping. Understanding the Fast Regain Doctors believe the mechanism of the injections accounts for the accelerated rebound. These medications mimic a natural hormone called glucagon-like peptide-1, which moderates hunger. "Sustained high doses of the hormone concentrations far above than normal might result in the system to produce less of its endogenous hormone, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist. "Withdrawal of this medication results in appetite is uncontrolled, making binge eating much more probable." An Ongoing Condition? Medical guidelines suggest the jabs for people with obesity-related health risks, accompanied by recommended diet and exercise modifications. Many experts argue that, due to the significant potential of relapse, the treatment should be considered life-long. This opinion is supported by pharmaceutical companies, who say that the results "highlight the persistent character of obesity," comparing it to managing conditions like high blood pressure. User Testimonies Users who have discontinued the jabs report a sudden resurgence of appetite. "It felt as if something activating and I was suddenly ravenous," described an individual. This difficulty is exacerbated if patients have not established sustainable lifestyle or habit modifications during therapy. Widespread Use Survey data indicate that a significant number of people in the UK have used these injections in the past year, with demand continuing to grow. Adoption is more common among females compared to males. The middle-aged age group shows the highest level of interest. A large proportion obtain the drugs through private prescriptions rather than public health services. In conclusion, experts emphasize that while GLP-1 drugs are potent agents for weight loss, they are not a magic solution and lasting health benefits likely depends on ongoing lifestyle support.
Weight management involves long-term strategies. A recent study reveals that people who stop using popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight far faster than those who halt traditional lifestyle regimens. Research printed in a major health publication demonstrates that while obese people frequently drop about a fifth of their total mass while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit. "Individuals using these medications must be cognizant of the potential of quick weight regain when the treatment concludes," cautioned researcher Dr. Susan Jebb. Such speed of regain means a reversion to starting mass within about one and a half years. Weighing Treatments The research, which reviewed 37 of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills. Researchers note that people who shed pounds through diet and exercise usually experience a more gradual weight regain—around 0.1 kg a month—after stopping. Understanding the Fast Regain Doctors believe the mechanism of the injections accounts for the accelerated rebound. These medications mimic a natural hormone called glucagon-like peptide-1, which moderates hunger. "Sustained high doses of the hormone concentrations far above than normal might result in the system to produce less of its endogenous hormone, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist. "Withdrawal of this medication results in appetite is uncontrolled, making binge eating much more probable." An Ongoing Condition? Medical guidelines suggest the jabs for people with obesity-related health risks, accompanied by recommended diet and exercise modifications. Many experts argue that, due to the significant potential of relapse, the treatment should be considered life-long. This opinion is supported by pharmaceutical companies, who say that the results "highlight the persistent character of obesity," comparing it to managing conditions like high blood pressure. User Testimonies Users who have discontinued the jabs report a sudden resurgence of appetite. "It felt as if something activating and I was suddenly ravenous," described an individual. This difficulty is exacerbated if patients have not established sustainable lifestyle or habit modifications during therapy. Widespread Use Survey data indicate that a significant number of people in the UK have used these injections in the past year, with demand continuing to grow. Adoption is more common among females compared to males. The middle-aged age group shows the highest level of interest. A large proportion obtain the drugs through private prescriptions rather than public health services. In conclusion, experts emphasize that while GLP-1 drugs are potent agents for weight loss, they are not a magic solution and lasting health benefits likely depends on ongoing lifestyle support.